Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhinitis Treatment and Infraorbital Shiners
NCT05348148Recruiting
- Sponsor
- Lotung St. Mary's Hospital
- Start
- Jun 2020
- Primary completion
- Mar 2032
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of mometasone furoate nasal spray and levocetirizine in allergic rhinitis (AR) and vasomotor rhinitis (VMR) (3 arms), sponsored by Lotung St. Mary's Hospital. Primary endpoints: Alleviating darkness of shiners at 1 week, Alleviating darkness of shiners at 2 weeks and 4 more. Started Jun 2020; status: recruiting.
02
Drugs
mometasone furoate nasal spraylevocetirizine
03
Conditions
allergic rhinitis (AR)vasomotor rhinitis (VMR)
Beyond the preview
Go deeper on NCT05348148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05348148.